Wipro inks deal with ComplianceQuest for management solutions

Information technology (IT) services firm Wipro has entered into a partnership with Tampa, Florida-based cloud-based enterprise quality and safety management system (QHSE)  provider ComplianceQuest, to build management solutions for the medical devices and life sciences industries.  

The solution, backed by the ComplianceQuest EQMS product platform and Wipro, will provide end-to-end quality management support to customers, according to a joint statement. 

“We intend to grow our joint offerings from full services complaints handling to digitally transforming quality and safety management operations globally,” Prashanth Rajendran, chief executive officer (CEO), ComplianceQuest said. 

Read: Wipro and Plexis Healthcare partner to deliver digital-first healthcare plan solutions

Founded in 2013 by Atulya Risal, Govardhan Muralidhar, and Prashanth Rajendran, ComplianceQuestis natively built and run on the Salesforce platform. It helps life sciences, medical devices, and other manufacturers meet their quality, safety, and compliance targets by connecting all relevant processes across the company and with its global supply networks.

The joint solution will enable medical devices and pharmaceutical companies to remain compliant, handle their complaints effectively, and comply with medical device reporting procedures and recall requirements.

“Organizations committed to patient safety and regulatory compliance will benefit immensely from the combination of the ComplianceQuest solution portfolio and Wipro’s consulting and transformation expertise,”  Nagendra P. Bandaru, president, Cloud and IT infrastructure services (CIS) and digital operations and platforms (DOP), Wipro said.

Bengaluru-based Wipro posted a flat growth of 0.1% in net profit to Rs 2,390 crore for the first quarter of the financial year 2020-21, amid the Covid-19 induced global economic crisis. Its healthcare vertical, manufacturing, energy, high-technology and consumer business unit verticals grew during the quarter.